Meet the $172.5 million biotech IPO from the U.K. with big plans to grow in the Bay Area

The London-based gene therapy company is planning a big East Bay manufacturing site
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.